C07C 233/70
Of a saturated carbon skeleton containing rings
Official title: of a saturated carbon skeleton containing rings
C07C233/70 (Of a saturated carbon skeleton containing rings) appears on 12 US grants and 14 published applications in this corpus.
Search patents in C07C- Granted patents
- 12
- Published applications
- 14
- Assignees
- 11
- Inventors
- 61
- Latest grant
- 7 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 2 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 2 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof7 Oct 2025US 12,435,051 B2Vivozon Inc.
- Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof13 Aug 2024US 12,060,339 B2Vivozon Inc.
- Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase16 Nov 2021US 11,173,145 B2Board of Regents, The University of Texas System
- Benzoic acid amide compound20 Aug 2019US 10,385,011 B2Amorepacific Corporation
- Amide compounds, compositions and uses thereof15 Sep 2015US 9,133,122 B2Evotec AG
- Pharmaceutical composition for preventing or treating mental disorder30 Oct 2025US 2025/0332138 A1Vivozon Inc.
- Dual modulator of mglur5 and 5-ht2a receptor, and use thereof31 Oct 2024US 2024/0360092 A1Vivozon Inc.
- Dual modulator of mglur5 and 5-ht2a receptor, and use thereof1 Sep 2022US 2022/0274939 A1Vivozon Inc.
- Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase5 Dec 2019US 2019/0365718 A1Board of Regents, The University of Texas System
- Novel benzoic acid amide compound8 Mar 2018US 2018/0065922 A1Amorepacific Corporation
Most cited
By later US patents
- Certain isoquinoline derivatives having anti-tumor properties33US 5,663,179 ALaboratoires Glaxo SA · 1997
- Biphenylcarboxylic amide derivatives as p38 kinase inhibitors6US 7,271,289 B2SmithKline Beecham Corporation · 2007
- Cyclohexanesulfonyl derivatives as GlyT1 inhibitors to treat schizophrenia3US 7,626,056 B2Merck Sharp & Dohme Corp. · 2009
- Benzoic acid amide compound1US 10,385,011 B2Amorepacific Corporation · 2019